Clinical trial
A Multicenter, Double-blind, Randomized, Parallel Group, Stratified Study to Assess the Safety and Efficacy of Single IV Doses of Palonosetron to Prevent Postoperative Nausea and Vomiting in Pediatric Patients
NCT00828295 is registered in ClinicalTrials.gov with Helsinn Healthcare SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Double-blind, Randomized, Parallel Group, Stratified Study to Assess the Safety and Efficacy of Single IV Doses of Palonosetron to Prevent Postoperative Nausea and Vomiting in Pediatric Patients
- Lead sponsor
- Helsinn Healthcare SA
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 2008
- Completion date
- January 31, 2009
- Enrollment
- 150 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.